Compile Data Set for Download or QSAR
Report error Found 226 Enz. Inhib. hit(s) with all data for entry = 12583
Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712286BDBM712286(US20250011311, Example 103)
Affinity DataIC50: 26nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712204BDBM712204(US20250011311, Example 21)
Affinity DataIC50: 32nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712216BDBM712216(US20250011311, Example 33)
Affinity DataIC50: 34nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712187BDBM712187(US20250011311, Example 4)
Affinity DataIC50: 36nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712186BDBM712186(US20250011311, Example 3)
Affinity DataIC50: 36nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712196BDBM712196(US20250011311, Example 13)
Affinity DataIC50: 40nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712189BDBM712189(US20250011311, Example 6)
Affinity DataIC50: 41nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712275BDBM712275(US20250011311, Example 92)
Affinity DataIC50: 41nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712307BDBM712307((5-(2-Bromo-3,4,6-trifluoro-5-hydroxyphenyl)-1,2,4...)
Affinity DataIC50: 42nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712303BDBM712303(US20250011311, Example 120)
Affinity DataIC50: 44nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712251BDBM712251((4-((5-Methoxypyridin-2- yl)oxy)piperidin-1-yl)(5-...)
Affinity DataIC50: 44nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712245BDBM712245((4-Phenyl-3,6- dihydropyridin- 1(2H)-yl)(5-(2,4,5-...)
Affinity DataIC50: 46nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712297BDBM712297(US20250011311, Example 114)
Affinity DataIC50: 46nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712292BDBM712292(US20250011311, Example 109)
Affinity DataIC50: 46nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712191BDBM712191(US20250011311, Example 8)
Affinity DataIC50: 47nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712279BDBM712279(US20250011311, Example 96)
Affinity DataIC50: 47nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712277BDBM712277(US20250011311, Example 94)
Affinity DataIC50: 48nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712247BDBM712247((3,4- Dihydroisoquinolin-2(1H)- yl)(5-(2,4,5-trifl...)
Affinity DataIC50: 48nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712244BDBM712244((4-(3-Methoxyphenyl) piperazin-1-yl)(5- (2,4,5-tri...)
Affinity DataIC50: 50nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712284BDBM712284(US20250011311, Example 101)
Affinity DataIC50: 50nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712285BDBM712285(US20250011311, Example 102)
Affinity DataIC50: 52nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712278BDBM712278(US20250011311, Example 95)
Affinity DataIC50: 53nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712287BDBM712287(US20250011311, Example 104)
Affinity DataIC50: 57nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712220BDBM712220(((3R,5S)-3,5- Dimethylpiperidin-1- yl)(5-(2,4,5-tr...)
Affinity DataIC50: 57nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712213BDBM712213(US20250011311, Example 30)
Affinity DataIC50: 61nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712255BDBM712255((4-(Benzo[d]oxazol-2- yl)piperazin-1-yl)(5-(2,4,5-...)
Affinity DataIC50: 62nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712265BDBM712265(2-(4-(5-(2,4,5-Trifluoro-3- hydroxyphenyl)-1,2,4- ...)
Affinity DataIC50: 62nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712281BDBM712281(US20250011311, Example 98)
Affinity DataIC50: 63nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712276BDBM712276(US20250011311, Example 93)
Affinity DataIC50: 63nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712203BDBM712203(US20250011311, Example 20)
Affinity DataIC50: 63nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712254BDBM712254(N-((5,6-Dimethyl-1H- benzo[d]imidazol-2-yl) methyl...)
Affinity DataIC50: 68nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712194BDBM712194(US20250011311, Example 11)
Affinity DataIC50: 69nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712260BDBM712260((1-Phenyl-3- azabicyclo[3.1.0]hexan-3- yl)(5-(2,4,...)
Affinity DataIC50: 75nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712185BDBM712185(US20250011311, Example 2)
Affinity DataIC50: 75nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712306BDBM712306((6-Methyl-5-oxa-8-azaspiro[3.5]nonan-8-yl)(5-(2,4,...)
Affinity DataIC50: 77nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712250BDBM712250((4-(3-Chloro-5-(2-methyl-2H- tetrazol-5-yl)pyridin...)
Affinity DataIC50: 79nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712201BDBM712201(US20250011311, Example 18)
Affinity DataIC50: 80nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712291BDBM712291(US20250011311, Example 108)
Affinity DataIC50: 80nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712224BDBM712224((Hexahydrocyclopenta [b][1,4] oxazin-4(4aH)-yl) (5...)
Affinity DataIC50: 82nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712190BDBM712190(US20250011311, Example 7)
Affinity DataIC50: 83nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712305BDBM712305(rac-((2R,6S)-2-isopropyl-6-methylmorpholino)(5-(2,...)
Affinity DataIC50: 85nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712240BDBM712240((4-(3-(4- Fluorophenoxy) propyl)piperazin- 1-yl)(5...)
Affinity DataIC50: 88nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712256BDBM712256(N-Methyl-N-((5-methyl- 1H-benzo[d]imidazol- 2-yl)m...)
Affinity DataIC50: 88nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712257BDBM712257((3-(4-Fluorophenyl)azetidin- 1-yl)(5-(2,4,5- trifl...)
Affinity DataIC50: 89nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712294BDBM712294(US20250011311, Example 111)
Affinity DataIC50: 93nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712188BDBM712188(US20250011311, Example 5)
Affinity DataIC50: 93nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712264BDBM712264((4-Phenylpiperazin-1-yl)(5- (2,4,5-trifluoro-3- hy...)
Affinity DataIC50: 95nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712269BDBM712269(US20250011311, Example 86)
Affinity DataIC50: 102nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712266BDBM712266(4-(4-(5-(2,4,5-Trifluoro-3- hydroxyphenyl)-1,2,4- ...)
Affinity DataIC50: 102nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Astrazeneca

US Patent
LigandChemical structure of BindingDB Monomer ID 712241BDBM712241((4-(Pyridin-2-yl) piperazin-1-yl)(5- (2,4,5-triflu...)
Affinity DataIC50: 103nMAssay Description:Final assay conditions were 80 nM of 17bHSD13, 0.5 mM of NAD, 20 μM Estradiol and various concentrations of compound in buffer (5 mM EDTA (TEKNOVA E0...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/22/2025
Entry Details
US Patent

Displayed 1 to 50 (of 226 total ) | Next | Last >>
Jump to: